article thumbnail

Petrie-Flom Welcomes 2023-2024 Student Fellows

Bill of Health

2024) in the Berkeley-Harvard Exchange Program. His current research focuses on tensions between the patent incentive system, the FDA approval process, and insurance carriers. She has previously published research papers on transplant immunology, birth tourism in the Canadian health care system, and global COVID-19 seroprevalence.

Bioethics 144
article thumbnail

Lucira Health Secures $80M to Expand COVID-19 Test Kit

HIT Consultant

. – Lucira’s COVID-19 testing platform produces lab-quality molecular testing in a single-use, consumer-friendly, palm-size test kit powered by two AA batteries. A fourth tranche of $15M may be made available prior to March 15, 2024, as determined by Hercules and SVB.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

The Commission will take more steps this and next year, including legislative measures, financial support, and creating an EU Drugs Agency by summer 2024. PCPC will continue to offer feedback to the FDA on the agency’s implementation of MoCRA and is encouraging member companies to prepare for registration and listing.

FDA 52
article thumbnail

President Biden Signs End-of-Year Legislation Including Telehealth, Medicare & Medicaid, Mental Health, Pandemic Preparedness, and Other Health Care Provisions

C&M Health Law

Notably, the Act neither fulfilled the Biden Administration’s request for additional COVID-19 response funding nor included the Verifying Accurate Leading-edge In Vitro Clinical Test (IVCT) Development (VALID) Act, which proposed updating the current diagnostic testing regulatory framework.

Medicaid 104
article thumbnail

The VALID Act: Senate Action Brings FDA Regulation of LDTs Closer to Fruition

Health Law Advisor

Since the passage of the Medical Device Amendments of 1976, FDA has regulated in vitro diagnostic (IVD) tests as medical devices, subject to a full suite of FDA requirements. FDA’s approach changed in 2014 when it issued draft guidance describing a plan to phase out FDA enforcement discretion and regulate LDTs.

FDA 52
article thumbnail

Where telemedicine is headed now that the PHE has ended

Healthcare IT News - Telehealth

The COVID-19 public health emergency came to an end on May 11. This also happens to coincide with the World Health Organization declaring an end to the COVID-19 global health emergency. This also happens to coincide with the World Health Organization declaring an end to the COVID-19 global health emergency.

article thumbnail

Medical Device Cybersecurity Provisions Included in Omnibus Appropriations Bill

HIPAA Journal

In September, the Food and Drug Administration (FDA) appropriations bill was passed to ensure the FDA continued to be funded, but in order for the bill to be passed, the FDA was forced to drop its proposed medical device cybersecurity requirements, many of which were taken from The Protecting and Transforming Cyber Health Care (PATCH) Act.

FDA 103